Medivir: Tango Project Cancelled - Redeye
Bildkälla: Stockfoto

Medivir: Tango Project Cancelled - Redeye

Redeye comments on Tango Therapeutics' discontinuation of the USP1 programme (TNG348), which does not have an impact on our base case.

Börsvärldens nyhetsbrev